Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene

被引:0
|
作者
Jian-Hua Mao
Jesus Perez-losada
Di Wu
Reyno DelRosario
Ryosuke Tsunematsu
Keiichi I. Nakayama
Ken Brown
Sheila Bryson
Allan Balmain
机构
[1] University of California at San Francisco,Cancer Research Institute
[2] Kyushu University,Department of Molecular and Cellular Biology, Medical Institute of Bioregulation
[3] University of Glasgow,CRC Department of Medical Oncology
来源
Nature | 2004年 / 432卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The FBXW7/hCDC4 gene encodes a ubiquitin ligase implicated in the control of chromosome stability1. Here we identify the mouse Fbxw7 gene as a p53-dependent tumour suppressor gene by using a mammalian genetic screen for p53-dependent genes involved in tumorigenesis. Radiation-induced lymphomas from p53+/- mice, but not those from p53-/- mice, show frequent loss of heterozygosity and a 10% mutation rate of the Fbxw7 gene. Fbxw7+/- mice have greater susceptibility to radiation-induced tumorigenesis, but most tumours retain and express the wild-type allele, indicating that Fbxw7 is a haploinsufficient tumour suppressor gene. Loss of Fbxw7 alters the spectrum of tumours that develop in p53 deficient mice to include a range of tumours in epithelial tissues such as the lung, liver and ovary. Mouse embryo fibroblasts from Fbxw7-deficient mice, or wild-type mouse cells expressing Fbxw7 small interfering RNA, have higher levels of Aurora-A kinase, c-Jun and Notch4, but not of cyclin E. We propose that p53-dependent loss of Fbxw7 leads to genetic instability by mechanisms that might involve the activation of Aurora-A, providing a rationale for the early occurrence of these mutations in human cancers.
引用
收藏
页码:775 / 779
页数:4
相关论文
共 50 条
  • [41] Notch- and P53-dependent crosstalk between tumour and stromal cells
    Novikova, M. V.
    Dugina, V.
    Kopnin, B.
    Khromova, N.
    Kopnin, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S1236 - S1236
  • [42] Involvement of the p53/p21 complex in p53-dependent gene expression
    Kim, Ukjin
    Kim, Kwang Seok
    Park, Jong-Kuk
    Um, Hong -Duck
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 621 : 151 - 156
  • [43] Correlation of tumour suppressor gene p53 expression with pathohistological tumour characteristics
    Petrovic, Dusica
    Mitrovic, Slobodanka
    Knezevic, Milan
    Azanjac, Goran
    Tanaskovic, Irena
    Radovanovic, Dragce
    Preljevic, Ibrahim
    Stankovic, Vesna
    HEALTHMED, 2012, 6 (01): : 156 - 163
  • [44] p53 Tumour suppressor gene expression in pancreatic neuroendocrine tumour cells
    Bartz, C
    Ziske, C
    Wiedenmann, B
    Moelling, K
    GUT, 1996, 38 (03) : 403 - 409
  • [45] Is tumour suppressor gene p53 involved in neuroendocrine tumour carcinogenesis? Reply
    Wang, DG
    Johnston, CF
    JOURNAL OF PATHOLOGY, 1996, 178 (03): : 360 - 360
  • [46] 蛋白Fbxw7α与P53相互作用的研究
    秦康
    朱智甲
    孟爽
    孟丽媛
    生物化工, 2019, 5 (02) : 7 - 10
  • [47] p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis
    Okamura, S
    Arakawa, H
    Tanaka, T
    Nakanishi, H
    Ng, CC
    Taya, Y
    Monden, M
    Nakamura, Y
    MOLECULAR CELL, 2001, 8 (01) : 85 - 94
  • [48] Gliomagenesis Arising from Pten- and Ink4a/Arf-Deficient Neural Progenitor Cells Is Mediated by the p53-Fbxw7/Cdc4 Pathway, Which Controls c-Myc
    Kim, Hong Sug
    Woolard, Kevin
    Lai, Chen
    Bauer, Peter O.
    Maric, Dragan
    Song, Hua
    Li, Aiguo
    Kotliarova, Svetlana
    Zhang, Wei
    Fine, Howard A.
    CANCER RESEARCH, 2012, 72 (22) : 6065 - 6075
  • [49] P53 tumour suppressor gene and germ cell neoplasia
    Lutzker, SG
    APMIS, 1998, 106 (01) : 85 - 89
  • [50] DMPK is a New Candidate Mediator of Tumor Suppressor p53-Dependent Cell Death
    Itoh, Katsuhiko
    Ebata, Takahiro
    Hirata, Hiroaki
    Torii, Takeru
    Sugimoto, Wataru
    Onodera, Keigo
    Nakajima, Wataru
    Uehara, Ikuno
    Okuzaki, Daisuke
    Yamauchi, Shota
    Budirahardja, Yemima
    Nishikata, Takahito
    Tanaka, Nobuyuki
    Kawauchi, Keiko
    MOLECULES, 2019, 24 (17):